Collapse of the Global Order on Drugs: From UNGASS 2016 to Review 2019

Axel Klein
Global Drug Policy Observatory, UK

Blaine Stothard
Independent Consultant, UK


List price $100.00 Add to basket
Product Details
Format:
Hardback
ISBN:
9781787564886
Published:
28 Sep 2018
Publisher:
Emerald Publishing Limited
Dimensions:
328 pages - 152 x 229mm
This book describes the events, activities and negotiations leading up to the 2016 UN General Assembly Special Session on international drug policy. A range of respected authors from International institutions, academia and civil society organisations detail the background to the negotiations and the outcome; and possible future scenarios for continued reform and change at the High Level Review in 2019. The chapters include consideration of the positions taken by blocs and nation-states at all points on the prohibition – reform continuum. Topics covered include discussions on the importance of human rights, access to essential medicines and the role played by cannabis in revealing the contradictions and divisions in both national and international contexts. The break-down of the previous international consensus on ‘the world drug problem’ is clearly described and analysed, as is the slow progress being made to the adoption of a human rights and health-based approach to currently illegal drugs. Consideration is also given to the nations and arguments which continue to defend prohibition and its repressive impacts on national populations, and the prioritising of geo-politics over population health this represents in practice. There are lessons and examples here for international politics and national policy reform.
Foreword; Michel Kazatchkine 
Introduction; Axel Klein and Blaine Stothard  
Chapter 1. The 2016 UNGASS on Drugs: A Catalyst for the Drug Policy Reform Movement; Ann Fordham Fordham and Heather Haase  
Chapter 2. The Death Penalty for Drug Offences: Pulling Back the Curtain to Expose a Flawed Regime; Gen Sander and Rick Lines 
Chapter 3. Measuring the ‘World Drug Problem’: 2019 and Beyond; David R. Bewley-Taylor and Marie Nougier
Chapter 4. Improving Access to Internationally Controlled Essential Medicines in the Post-UNGASS, Agenda 2030 Framework; Katherine Irene Pettus  
Chapter 5. The Elephant in the Room: Cannabis in the International Drug Control Regime; Tom Blickman  
Chapter 6. Drug Policy in the Russian Federation: Do Control Policies Produce More Harm Than Drugs?; Mikhail Golichenko, Anya Sarang, Khalid Tinasti and Isabela Barbosa  
Chapter 7. Consensus and Contradictions in ASEAN: An Analysis of Southeast Asia at and After UNGASS 2016; Ricky Gunawan and Gloria Lai  
Chapter 8. Deconstructing the Islamic Bloc: The Middle East and North Africa and Pluralistic Drugs Policy; Maziyar Ghiabi  
Chapter 9. Breaking Ranks: Pioneering Drug Policy Protagonism in Uruguay and Bolivia; Jonas von Hoffmann
Chapter 10. The Netherlands, Portugal and the Czech Republic: Political Perceptions and Legal Realities; Danilo Ballotta and Brendan Hughes 
Chapter 11. The European Union in Panglossian Stagnation; Caroline Chatwin  
Chapter 12. United States Drug Policy: Flexible Prohibition and Regulation; Zara Snapp and Jorge Herrera Valderrábano 
Chapter 13. West Africa; Leandre Banon and Maria-Goretti Loglo 
Chapter 14. Switzerland: Moving Towards Public Health and Harm Reduction; Frank Zobel and Larissa J. Maier
Chapter 15. Epilogue; Mike Trace
Axel Klein is a researcher and project consultant with a long standing commitment to drug policy reform. Axel has headed the research and international units at DrugScope and been a trustee for Transform, two UK NGOs. is publications include The Khat Controversy: Stimulating the Debate on Drugs (2007), Caribbean Drugs: From Criminalization to Harm Reduction (2004), and Drugs and the World (2009). More recently Axel has published on cannabis cultivation and the anthropology of drugs. He has been the editor of journal Drugs and Alcohol Today since 2007.
Blaine Stothard is an educationalist and prevention specialist who came to drug policy through an advisory role in a London LEA at the time of the UK’s first national drug policy. He was active in the Healthy Schools programmes from 1998 to 2010 as an independent consultant, has worked on related policy development and implementation in the UK and Eastern Europe and was the external consultant for the Moscow-based schools drug education programme run by Project HOPE from 1998 to 2006. He has been the co-editor of Drugs and Alcohol Today since 2014.

You might also be interested in..

« Back